From: Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism
n | 30 |
Age (mean ± SD) | 62 ± 14 |
Male | 17/30 (57Â %) |
CTA confirmed central PE (pulmonary trunk, main pulmonary arteries) | 100Â % |
Risk stratefication (PE-related early mortality rate) | |
 High (>15 %) | 4/30 (13 %) |
 Intermediate (3–15 %) | 15/30 (50 %) |
 Low (<1 %) | 11/30 (37 %) |
Symptoms | |
 Dyspnoea | 24/30 (81 %) |
 Chest pain | 10/30 (33 %) |
 Cough | 3/30 (10 %) |
 Syncope | 3/30 (10 %) |
 Haemoptysis | 2/30 (7 %) |
 Collaps with subsequent CPR | 4/30 (13 %) |
Idiopathic DVT/PE | 13/30 (43Â %) |
Secondary DVT/PE | |
 Malignancy | 4/30 (13 %) |
 Post surgery | 4/30 (13 %) |
 Immobilisation | 2/30 (7 %) |
 Thrombophilia | 1/30 (3 %) |
 Previous DVT/PE | 2/30 (7 %) |
 Oral contraceptive therapy | 2/30 (7 %) |
 Obesity (BMI ≥ 30 kg/m2) | 12/30 (40 %) |
US confirmed DVT | 25/30 (83Â %) |